PairX is pioneering the development of next-generation cancer-selective biologics by identifying novel, highly prevalent, tumor-selective cell surface variants. Our biology-driven approach reveals a new class of therapeutic targets that can be paired with a variety of optimal therapeutic modalities. Founded on IP exclusively licensed from Duke-NUS Medical School, Singapore, PairX is advancing a robust pipeline of potential first- and best-in-class tumor-selective therapies targeting prevalent cancers in substantial patient populations.
Company Details
- Employees
- 4
- Founded
- 2020
- Address
- 21 Biopolis Road, Singapore,138567,singapore
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.pairxbio.com
- HQ
- Singapore
Pairx Bio Questions
Pairx Bio's website is https://www.pairxbio.com
Pairx Bio's LinkedIn profile is https://sg.linkedin.com/company/pairxbio
Pairx Bio has
4 employees.
View email and phone details for 4
employees at Pairx Bio.
Pairx Bio's industry is
Biotechnology Research
Pairx Bio's top competitors are
Albatroz Therapeutics,
Panacea Venture,
Black Diamond Therapeutics,
Engine Biosciences,
Vertex Growth,
Nsg Biolabs,
Co11ab Novena,
Biotech Connection Singapore,
Probio,
Hummingbird Bioscience.
Pairx Bio's categories are Biotechnology Research
Pairx Bio's founding year is 2020
